• Bacillus ACT 2015

    The Grand New Delhi Nelson Mandela Road, New Delhi, India

    The International Conference on Bacillus anthracis, B. cereus and B. thuringiensis, Bacillus ACT 2015, will be held October 27-31, 2015 in New Delhi, India. The conference is held every other year, with the 2013 conference hosted in Victoria, British Columbia. Leading scientists and researchers from all over the world will gather at the conference to

  • CBRNe Convergence 2015

    Rosen Plaza 9700 International Drive, Orlando, United States

    The CBRNe Convergence 2015 Congress & Exhibition will take place October 28-30, 2015 in Orlando, Florida. Organized by CBRNe World, the event features presentations by dozens of leading subject-matter experts, an exhibition of more than 60 select companies, and a dynamic demonstration of U.S. CBRNE and hazmat assets coordinated by the FBI WMD Directorate. Highlighted

  • APHA Annual Meeting 2015

    McCormick Place 2301 S. Lake Shore Drive, Chicago, United States

    The APHA Annual Meeting 2015 will take place October 31 - November 4, 2015 in Chicago, IL United States. The meeting aims to strengthen the profession of public health, share the latest research and information, promote best practices and advocate for public health issues and policies grounded in research. This meeting brings together more than

  • 4th ASM-ESCMID Conference

    Radisson Blu Aqua Hotel 221 N. Columbus Drive, Chicago, IL, United States

    American Society for Microbiology's 4th ASM-ESCMID Conference on Methicillin-resistant Staphylococci in Animals: Veterinary and Public Health Implications is scheduled to take place Nov. 2-5, 2015 in Chicago, IL. This conference focuses on the animal and public health aspects of methicillin-resistant staphylococci (MRS), including transmission of MRS between humans and animals (including livestock, companion animals and

  • AMP 2015 Annual Meeting

    Austin Convention Center 500 E Cesar Chavez St, Austin, TX, United States

    The AMP 2015 Annual Meeting is scheduled to take place November 5-7, 2015 in Austin, TX. Preceding the annual meeting on November 4th, a full day of corporate workshops will take place. Please visit the Association For Molecular Pathology's AMP 2015 Annual Meeting website for more information and registration.

  • World Vaccine Congress 2015

    Silken Puerta America Avda América,41 o Corazón de María,10, Madrid, Spain

    The World Vaccine Congress 2015 is scheduled to take place November 9-11, 2015 in Madrid, Spain. This meeting plans to examine the new technologies for vaccine development, including nanotech, synthetic biology and new-generation adjuvants.  Clinical phase I, II and III data from leading biotechs and big pharma will be presented.  Updates on the latest discovery-stage

  • European Antibody Congress 2015

    Congress Center Basel Messeplatz 21, Basel, Switzerland

    The European Antibody Congress 2015 is scheduled to take place November 9-11, 2015 in Basel, Switzerland. The conference will offer opportunities to learn about innovative new platforms and technologies; hear industry leader’s views on the clinical and commercial future of antibodies; and network with thought leaders and influencers in the industry. Highlighted topics include: Immune system

  • NCT CBRNe Asia 2015

    Dusit Thani Bangkok 946 Rama IV Road, Bangkok, Thailand

    The Non-Conventional Threat: CBRNe Asia 2015 will take place November 10-12 in Bangkok, Thailand. NCT CBRNe Asia provides one of the best opportunities to meet with and learn from regional CBRNe experts and stakeholders. After successful events in Thailand, Malaysia, and Cambodia, the conference returns this year to Thailand, connecting CBRNe stakeholders and decision makers

  • World Orphan Drug Congress 2015

    Starling Hotel Geneva Route François-Peyrot 34, Geneva, Switzerland

    The World Orphan Drug Congress 2015 will take place November 11-13, 2015 in Geneva, Switzerland. This conference will offer opportunities to discuss topics such as the pricing and reimbursement debate, commercialization challenges and engaging with patients during research and development of new therapies.  Interact with representatives from pharma, biotechs, payers, government, regulators, academia and patient